{"id":"W2922056055","doi":"10.1200/jco.2019.37.7_suppl.581","title":"Outcomes in patients (pts) with advanced renal cell carcinoma (aRCC) who discontinued (DC) first-line nivolumab + ipilimumab (N+I) or sunitinib (S) due to treatment-related adverse events (TRAEs) in CheckMate 214.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Randomized controlled trial; Diarrhea; Adverse effect; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009355164,0.0003048033,0.0006652698,0.0001977306,0.0002245711,0.0003655484,0.0002675542,0.000497153,0.001584119],"category_scores_gemma":[0.0009420351,0.0001819749,0.001239932,0.0003394754,0.000318564,0.0002896216,0.0002930162,0.0007493471,0.0001585919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007560653,"about_ca_system_score_gemma":0.0006708244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001477508,"about_ca_topic_score_gemma":0.002223606,"domain_scores_codex":[0.9997224,0.0001143249,0.00002307167,0.00006216315,0.00003118869,0.00004678834],"domain_scores_gemma":[0.9992656,0.0001565963,0.0002769901,0.00003489574,0.00003149283,0.0002344768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6357512,0.006832307,0.2681834,0.001177807,0.003870132,0.0005565167,0.0002259418,0.004065822,0.005962828,0.0002144621,0.004444048,0.0687155],"study_design_scores_gemma":[0.1558973,0.3358607,0.4933436,0.0001534326,0.004210505,0.0009903079,0.0001418109,0.002601071,0.002244052,0.0003680705,0.004146755,0.00004245438],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974837,0.001030205,0.0000786907,0.00006899404,0.00002580232,0.0001380804,0.0005931902,0.000006478031,0.0005749347],"genre_scores_gemma":[0.997903,0.0004030833,0.0001102721,0.0001511869,0.00004162386,0.0001826637,0.0009187586,0.000001828214,0.0002876193],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001584119,"threshold_uncertainty_score":0.005485713,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04543029092802406,"score_gpt":0.3627115971951943,"score_spread":0.3172813062671702,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}